Autopsy report · NCT03576963

Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer

“No funding”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

University of Southern California

Sponsor type

University, hospital or other

Conditions

Colorectal Adenocarcinoma; CpG Island Methylator Phenotype; Metastatic Microsatellite Stable Colorectal Carcinoma; Refractory Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8

Interventions

Guadecitabine; Nivolumab

Participants

0

Sites

2

Countries

United States

Trials that died the same way

• Prehabilitation in Patients on a Waiting List for a Transplant
  “No funded” (91% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.